Page 6 - 2020 Policy Watch-Comparison of Secret Sale Patent
P. 6
icy Watch: Comparison between the US and China as to Whether a Secret Sale before the Date of Filing Affacts the Patent Application

Introduction
å¼??

The following essay is a detailed analysis of the inspir- �????�elsinn Healthcare S.A. �eva
ing Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc. Pharms. USA, Inc.�?�???????�?�
case. The final Judicial decision indicates that a com- ???æ³??å®????????????????º¦å®???¡å?
mercial sale to a third party who is required to keep ???ä¿?????ä¸???????è¡?¸ºç¬??????½å???
the invention confidential may place the invention ??n �????�???????????�???
sale?? under the AIA.
Whereas the Chinese Patent Law does not specify an ?¶è???ä¸??ä¸??æ³?²¡??????å¸??å¯??ç¾????
on-sale bar like the Leahy-Smith American Invention ???æ¡????ç¡????????´â???????¸­?½è?为ç?
Act. It is held in China that whether a patent applica- 请æ????è¡?????ä¸???³è???????äº???©å?
tion that was on sale before the date of filing is pat- å®???¶æ??????????????¸º????½å??·å???
entable depends on whether it is disclosed or available å¦??å®??以为??????·ç?ï¼???????为使?¶æ?
to the public. If it is available to the public, the sale 为ç???????å¹¶å?此丧失å??°é??§ã?????¸­??
makes it a prior art and thus lose its novelty. A patent ????©æ????äº??äº??ï¼?¸§å¤±æ?é¢??§ç?ä¸????
application with a lack of novelty is un-patentable in 请ä??½è????ä¸??????
accordance with Article 22 of the Chinese Patent Law.

6
   1   2   3   4   5   6   7   8   9   10   11